Cochrane at crossroads over drug company sponsorship

摘要

The Cochrane Collaboration is divided over drug company sponsorship of systematic reviews Supporters say Cochrane needs commercial support and could benefit from company perspectives Opponents say sponsorship will influence research agendas and damage independence and integrity Mechanisms are being floated for industry to collectively sponsor Cochrane activities and avoid perceptions of influence.